- Home
- ZYXI vs SOPH Comparison
ZYXI vs SOPH Comparison
Compare ZYXI & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- SOPH
- Stock Information
- Founded
- ZYXI 1996
- SOPH 2011
- Country
- ZYXI United States
- SOPH Switzerland
- Employees
- ZYXI N/A
- SOPH N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZYXI Health Care
- SOPH Health Care
- Exchange
- ZYXI Nasdaq
- SOPH Nasdaq
- Market Cap
- ZYXI 44.8M
- SOPH 231.8M
- IPO Year
- ZYXI N/A
- SOPH 2021
- Fundamental
- Price
- ZYXI $1.50
- SOPH $3.23
- Analyst Decision
- ZYXI Hold
- SOPH
- Analyst Count
- ZYXI 3
- SOPH 0
- Target Price
- ZYXI $3.00
- SOPH N/A
- AVG Volume (30 Days)
- ZYXI 103.1K
- SOPH 38.8K
- Earning Date
- ZYXI 10-23-2025
- SOPH 11-04-2025
- Dividend Yield
- ZYXI N/A
- SOPH N/A
- EPS Growth
- ZYXI N/A
- SOPH N/A
- EPS
- ZYXI N/A
- SOPH N/A
- Revenue
- ZYXI $144,808,000.00
- SOPH $69,688,000.00
- Revenue This Year
- ZYXI N/A
- SOPH $16.60
- Revenue Next Year
- ZYXI $7.07
- SOPH $18.77
- P/E Ratio
- ZYXI N/A
- SOPH N/A
- Revenue Growth
- ZYXI N/A
- SOPH 7.32
- 52 Week Low
- ZYXI $1.23
- SOPH $2.58
- 52 Week High
- ZYXI $9.42
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- ZYXI 42.77
- SOPH 46.63
- Support Level
- ZYXI $1.44
- SOPH $3.10
- Resistance Level
- ZYXI $1.55
- SOPH $3.49
- Average True Range (ATR)
- ZYXI 0.09
- SOPH 0.16
- MACD
- ZYXI 0.02
- SOPH -0.02
- Stochastic Oscillator
- ZYXI 29.03
- SOPH 31.71
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.